Susquehanna International Group, LLP Alkermes Plc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $830,661 - $1.03 Million	-36,100 Reduced 38.49%	57,700 $1.62 Million
Q2 2024 Aug 15, 2024	SELL	$23.21 - $27.24 $174,075 - $204,300	-7,500 Reduced 7.4%	93,800 $2.26 Million
Q1 2024 May 07, 2024	BUY	$26.4 - $32.56 $480,480 - $592,592	18,200 Added 21.9%	101,300 $2.74 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $154,242 - $189,288	6,600 Added 8.63%	83,100 $2.31 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $4.75 Million - $5.59 Million	-174,900 Reduced 69.57%	76,500 $2.14 Million
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $3.75 Million - $4.45 Million	132,200 Added 110.91%	251,400 $7.87 Million
Q1 2023 May 16, 2023	BUY	$25.31 - $29.02 $187,294 - $214,748	7,400 Added 6.62%	119,200 $3.36 Million
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $315,936 - $377,856	-14,400 Reduced 11.41%	111,800 $2.92 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $233,200 - $337,822	10,600 Added 9.17%	126,200 $2.82 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $2.32 Million - $2.68 Million	87,700 Added 314.34%	115,600 $3.44 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $643,653 - $780,921	27,900 New	27,900 $734,000
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $434,682 - $597,618	-18,600 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$18.78 - $25.15 $2.98 Million - $3.99 Million	-158,600 Reduced 89.5%	18,600 $456,000
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $2.72 Million - $3.47 Million	149,400 Added 537.41%	177,200 $3.31 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $352,431 - $506,090	-22,900 Reduced 45.17%	27,800 $555,000
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $111,504 - $142,554	-6,900 Reduced 11.98%	50,700 $840,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $432,575 - $630,825	32,500 Added 129.48%	57,600 $1.12 Million
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $306,307 - $381,196	-15,700 Reduced 38.48%	25,100 $490,000
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $229,729 - $399,431	-10,700 Reduced 20.78%	40,800 $920,000
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $187,440 - $240,834	6,600 Added 14.7%	51,500 $1.88 Million
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $7.68 Million - $12.3 Million	-274,700 Reduced 85.95%	44,900 $1.33 Million
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $4.95 Million - $5.91 Million	128,200 Added 66.98%	319,600 $13.6 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $1.47 Million - $1.86 Million	36,200 Added 23.32%	191,400 $7.88 Million
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $7.26 Million - $9.11 Million	135,500 Added 687.82%	155,200 $9 Million
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $95,380 - $110,780	2,000 Added 11.3%	19,700 $1.08 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $870,131 - $963,765	17,700	17,700 $900,000

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$865 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$564 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$386 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$376 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$273 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account